Cargando…

HRness in Breast and Ovarian Cancers

Ovarian and breast cancers are currently defined by the main pathways involved in the tumorigenesis. The majority are carcinomas, originating from epithelial cells that are in constant division and subjected to cyclical variations of the estrogen stimulus during the female hormonal cycle, therefore...

Descripción completa

Detalles Bibliográficos
Autores principales:	Santana dos Santos, Elizabeth, Lallemand, François, Petitalot, Ambre, Caputo, Sandrine M., Rouleau, Etienne
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7312125/ https://www.ncbi.nlm.nih.gov/pubmed/32481735 http://dx.doi.org/10.3390/ijms21113850

Ejemplares similares

Non-Coding Variants in BRCA1 and BRCA2 Genes: Potential Impact on Breast and Ovarian Cancer Predisposition
por: Santana dos Santos, Elizabeth, et al.
Publicado: (2018)

WWOX binds MERIT40 and modulates its function in homologous recombination, implications in breast cancer
por: Taouis, Karim, et al.
Publicado: (2023)

Involvement of the FOXO6 transcriptional factor in breast carcinogenesis
por: Lallemand, François, et al.
Publicado: (2017)

Intrinsic Disorder and Phosphorylation in BRCA2 Facilitate Tight Regulation of Multiple Conserved Binding Events
por: Julien, Manon, et al.
Publicado: (2021)

Combined Tumor-Based BRCA1/2 and TP53 Mutation Testing in Ovarian Cancer
por: Borcoman, Edith, et al.
Publicado: (2023)

Description and analysis of genetic variants in French hereditary breast and ovarian cancer families recorded in the UMD-BRCA1/BRCA2 databases
por: Caputo, Sandrine, et al.
Publicado: (2012)

Genetic Landscape of Male Breast Cancer
por: Campos, Fernando Augusto Batista, et al.
Publicado: (2021)

VOPP1 promotes breast tumorigenesis by interacting with the tumor suppressor WWOX
por: Bonin, Florian, et al.
Publicado: (2018)

Full in-frame exon 3 skipping of BRCA2 confers high risk of breast and/or ovarian cancer
por: Caputo, Sandrine M., et al.
Publicado: (2018)

The high protein expression of FOXO3, but not that of FOXO1, is associated with markers of good prognosis
por: Lallemand, François, et al.
Publicado: (2020)

Value of the loss of heterozygosity to BRCA1 variant classification
por: Santana dos Santos, Elizabeth, et al.
Publicado: (2022)

Identification of a large intra-exonic deletion in BRCA2 exon 18 in a pancreatic ductal adenocarcinoma
por: Debbabi, Inès, et al.
Publicado: (2023)

Expression analysis of mitotic spindle checkpoint genes in breast carcinoma: role of NDC80/HEC1 in early breast tumorigenicity, and a two-gene signature for aneuploidy
por: Bièche, Ivan, et al.
Publicado: (2011)

Molecular Functions of WWOX Potentially Involved in Cancer Development
por: Taouis, Karim, et al.
Publicado: (2021)

An entire exon 3 germ-line rearrangement in the BRCA2 gene: pathogenic relevance of exon 3 deletion in breast cancer predisposition
por: Muller, Danièle, et al.
Publicado: (2011)

Hereditary breast and ovarian cancer
por: Gronwald, Jacek, et al.
Publicado: (2008)

An Emerin LEM-Domain Mutation Impairs Cell Response to Mechanical Stress
por: Essawy, Nada, et al.
Publicado: (2019)

Familial Breast and Ovarian Cancer
por: Spence, R A J
Publicado: (2003)

PARP Inhibitors in Breast and Ovarian Cancer
por: Wang, Samuel S. Y., et al.
Publicado: (2023)

Mutation Patterns in Portuguese Families with Hereditary Breast and Ovarian Cancer Syndrome
por: Vicente, Rodrigo, et al.
Publicado: (2022)

Hereditary Breast-Ovarian Cancer Syndrome in Russia
por: Sokolenko, A.P., et al.
Publicado: (2010)

Di-phosphorylated BAF shows altered structural dynamics and binding to DNA, but interacts with its nuclear envelope partners
por: Marcelot, Agathe, et al.
Publicado: (2021)

Homologous recombination proficiency in ovarian and breast cancer patients
por: Creeden, Justin Fortune, et al.
Publicado: (2021)

Metalloproteinases in Ovarian Cancer
por: Carey, Preston, et al.
Publicado: (2021)

Structural analysis of the ternary complex between lamin A/C, BAF and emerin identifies an interface disrupted in autosomal recessive progeroid diseases
por: Samson, Camille, et al.
Publicado: (2018)

MiR-190b, the highest up-regulated miRNA in ERα-positive compared to ERα-negative breast tumors, a new biomarker in breast cancers?
por: Cizeron-Clairac, Geraldine, et al.
Publicado: (2015)

Platinum resistance in breast and ovarian cancer cell lines
por: Eckstein, Niels
Publicado: (2011)

Challenges of Genomic Testing for Hereditary Breast and Ovarian Cancers
por: McAlarnen, Lindsey, et al.
Publicado: (2021)

Nutraceutical-Based Nanoformulations for Breast and Ovarian Cancer Treatment
por: Serini, Simona, et al.
Publicado: (2022)

Animal models of ovarian cancer
por: Vanderhyden, Barbara C, et al.
Publicado: (2003)

The plasma peptides of breast versus ovarian cancer
por: Dufresne, Jaimie, et al.
Publicado: (2019)

Radiotherapy Advances in Renal Disease—Focus on Renal Ischemic Preconditioning
por: Khbouz, Badr, et al.
Publicado: (2023)

Therapeutic advances in hormone-dependent cancers: focus on prostate, breast and ovarian cancers
por: Ulm, Michael, et al.
Publicado: (2019)

Kindlin‐1 modulates the EGFR pathway and predicts sensitivity to EGFR inhibitors across cancer types
por: Azorin, Paula, et al.
Publicado: (2022)

A Bright Future for Fluorescence Imaging of Fungi in Living Hosts
por: Chapuis, Ambre F., et al.
Publicado: (2019)

An Overview on Radiation Sensitivity in Hereditary Breast and Ovarian Cancer Syndrome
por: Gonçalves, Diana, et al.
Publicado: (2022)

Biomarkers in Breast Cancer: An Old Story with a New End
por: Neves Rebello Alves, Lyvia, et al.
Publicado: (2023)

Antivascular Therapy for Epithelial Ovarian Cancer
por: Duhoux, Francois P., et al.
Publicado: (2010)

Quantification of Bevacizumab Activity Following Treatment of Patients With Ovarian Cancer or Glioblastoma
por: Lallemand, Christophe, et al.
Publicado: (2020)

Protective Effects of Epigallocatechin Gallate (EGCG) on Endometrial, Breast, and Ovarian Cancers
por: Huang, Yun-Ju, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_8nncdieanoj9njoc6lj4agsc0b